Can NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary COMMENT
| dc.authorid | 0000-0002-6314-7371 | en_US |
| dc.contributor.author | Köse, Nuri | |
| dc.contributor.author | Yıldırım, Tarık | |
| dc.contributor.author | Akın, Fatih | |
| dc.contributor.author | Yıldırım, Seda Elçim | |
| dc.contributor.author | Altun, İbrahim | |
| dc.date.accessioned | 2022-09-13T11:29:58Z | |
| dc.date.available | 2022-09-13T11:29:58Z | |
| dc.date.issued | 2021 | en_US |
| dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.description | Yıldırım, Tarık (Balikesir Author) | en_US |
| dc.description.abstract | We appreciate the comments made by Dr. Bedel et al. NLR, PLR, and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Due to this, we have listed some of the dis-orders mentioned above in the tables. Hematological diseases, collagen tissue disease, inflammatory diseases, congenital heart disease, or severe renal/liver disease were excluded from the study. However, the presence of malignancy did not affect our results in the regression analysis. | en_US |
| dc.identifier.doi | 10.17305/bjbms.2020.5292 | |
| dc.identifier.endpage | 502 | en_US |
| dc.identifier.issn | 1512-8601 | |
| dc.identifier.issn | 1840-4812 | |
| dc.identifier.issue | 4 | en_US |
| dc.identifier.scopus | 2-s2.0-85112133383 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 502 | en_US |
| dc.identifier.uri | https://doi.org/10.17305/bjbms.2020.5292 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12462/12481 | |
| dc.identifier.volume | 21 | en_US |
| dc.identifier.wos | WOS:000674672700016 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | en_US |
| dc.publisher | Assoc Basic Medical Sci Federation Bosnia & Herzegovina Sarajevo | en_US |
| dc.relation.ispartof | Bosnian Journal of Basic Medical Sciences | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.subject | Research & Experimental Medicine | en_US |
| dc.title | Can NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary COMMENT | en_US |
| dc.type | Editorial | en_US |
